TUCSON   520.748.4400

  • Creating partnerships to change medicine

    Partnering with entrepreneurs, founders, innovators and inventors to drive forward success.

  • Developing tomorrow's biotechnology and medical device innovation

    Translating next generation life science inventions from concepts to patents, then patents to commercial products.

  • AdvaMed 2015 hosts MedTech Innovator Competition

    AdvaMed and RCT announce that the 2015 finals of the MedTech Innovator competition will take place at AdvaMed 2015.

  • Licensing breakthrough technologies in the life sciences

    RCT licenses new, promising biomedical technologies and products to industry.

Offering biomedical innovators the experience, expertise, and funding required for success.

Ventures

Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›

Technologies

RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›

News & Events

10.25.2017

CDC RECOMMENDS SHINGRIX AS THE PREFERRED VACCINE FOR THE PREVENTION OF SHINGLES FOR ADULTS AGED 50 AND OLDER

GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted in favor of three recommendations for the use of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention … Learn more ›